Literature DB >> 25854490

Difficult clinical situations in the antiphospholipid syndrome.

Renata Ferreira Rosa1, Michelle Remião Ugolini-Lopes, Audrey Krüse Zeinad-Valim, Elbio D'Amico, Danieli Andrade.   

Abstract

Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL) associated with thrombosis and/or pregnancy morbidity. However, there is a range of other manifestations associated with APS, called non-criteria manifestations that add significant morbidity to this syndrome and, some of them, represent difficult clinical situations to deal with. Other issues such as refractory treatment also represent challenging situations poorly addressed in the literature. Therefore, the purpose of this article is to review the management of difficult clinical situations in APS and provide information to help the readers in their decision-making process.

Entities:  

Mesh:

Year:  2015        PMID: 25854490     DOI: 10.1007/s11926-015-0502-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  88 in total

1.  Thrombocytopenia in the antiphospholipid syndrome.

Authors:  M J Cuadrado; F Mujic; E Muñoz; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1997-03       Impact factor: 19.103

2.  Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.

Authors:  Elizabeth Kozora; Doruk Erkan; Lening Zhang; Robert Zimmerman; Glendalee Ramon; Aziz M Ulug; Michael D Lockshin
Journal:  Clin Exp Rheumatol       Date:  2013-09-10       Impact factor: 4.473

Review 3.  Cutaneous manifestations of antiphospholipid antibody syndrome.

Authors:  Sari Weinstein; Warren Piette
Journal:  Hematol Oncol Clin North Am       Date:  2008-02       Impact factor: 3.722

4.  Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome.

Authors:  I M Suarez; R A Diaz; D Aguayo Canela; E Pujol de la Llave
Journal:  Lupus       Date:  1996-02       Impact factor: 2.911

5.  Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome.

Authors:  D Alarcón-Segovia; J Sánchez-Guerrero
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

6.  Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.

Authors:  K E Moss; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-08       Impact factor: 7.580

7.  Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy.

Authors:  C Korkmaz; S Kabukcuoğlu; S Isiksoy; A U Yalçin
Journal:  Lupus       Date:  2003       Impact factor: 2.911

8.  Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Authors:  Guillaume Canaud; Frank Bienaimé; Fanny Tabarin; Guillaume Bataillon; Danielle Seilhean; Laure-Hélène Noël; Marie-Agnès Dragon-Durey; Renaud Snanoudj; Gérard Friedlander; Lise Halbwachs-Mecarelli; Christophe Legendre; Fabiola Terzi
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

9.  Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery.

Authors:  Yackov Berkun; Amir Elami; Karen Meir; Dror Mevorach; Yaakov Naparstek
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

Review 10.  The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy.

Authors:  R A Asherson; C Francès; L Iaccarino; M A Khamashta; F Malacarne; J C Piette; A Tincani; A Doria
Journal:  Clin Exp Rheumatol       Date:  2006 Jan-Feb       Impact factor: 4.473

View more
  4 in total

1.  [Painful recurrent leg ulcers].

Authors:  I Bertlich; A Enk; F Toberer
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

Review 2.  Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome.

Authors:  Rafid Mustafa
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-30       Impact factor: 6.030

Review 3.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

4.  Extensive abdominal wall ulceration as a late manifestation of antiphospholipid syndrome: a case report.

Authors:  Yogesh Sharma; Karen Humphreys; Campbell Thompson
Journal:  J Med Case Rep       Date:  2018-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.